Scott’s research focuses on the synthesis and preclinical validation of biomaterials-based immunomodulatory therapies that bias the adaptive immune response towards immunity or tolerance. Utilizing organic chemistry, the aim of Scott’s group is to synthesize bespoke biomaterials with specific immunomodulatory functionalities. In particular, Scott is interested in the development of immunity-inducing therapies for the treatment of malignancy and infectious disease as well as tolerance-induction strategies that knock out the antigen-specific immune responses driving autoimmunity, transplant rejections, and the immunogenicity of protein-based therapeutics. In addition to immunomodulatory therapies, Scott’s lab is also interested in platforms that modulate the spatial-temporal delivery of both small molecules and biologics.
- Assistant Professor, Biomedical Engineering
Affiliated Centers & Institutes
- PhD, Chemical Engineering: Bioengineering, Minor: Chemistry, Georgia Institute of Technology, 2011
- MS, Chemical Engineering, University of Oklahoma, 2004
- BS, Chemical Engineering, University of Oklahoma, 2001
May 20, 2020Scott Wilson joined the Johns Hopkins Department of Biomedical Engineering as an assistant professor in January 2020. In this interview, he discusses his research in biomaterials and immunoengineering, a memorable “eureka” moment, and his goals for the future.